Arvinas (ARVN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ARVN Arvinas

Watchlist

25.980
+1.500+6.13%

Close Nov 27 16:00 ET

25.980
0.0000.00%

Post 20:01 ET

1.79BMarket Cap-5423P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference
Dow JonesNov 27 07:00 ET
BMO Capital Maintains Arvinas(ARVN.US) With Buy Rating, Maintains Target Price $88
Moomoo NewsNov 26 08:32 ET · Ratings
Wells Fargo Maintains Arvinas(ARVN.US) With Buy Rating, Maintains Target Price $60
Moomoo NewsNov 26 05:34 ET · Ratings
Positive Outlook for Arvinas Due to Promising Safety Data and Upcoming Developments
TipRanksNov 26 04:56 ET
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer Symposium
GlobeNewswireNov 25 17:35 ET
Arvinas Holding's VERITAC-2 Trial Progress Drives Buy Rating Despite Adjusted Price Target
TipRanksNov 21 01:16 ET · Ratings

Comments

Moomoo AI

Feb 26 13:36

Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.

Revenues Not Telling The Story For Arvinas, Inc. (NASDAQ:ARVN) After Shares Rise 28%

Moomoo AI

Feb 20 15:08

Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.

Press Release: Arvinas Announces Chief Financial Officer Transition

Bigmoney Dreamer

Feb 7 00:21

$Arvinas (ARVN.US)$ 👀 new hoy

JP88

Dec 8, 2023 17:35

$Arvinas (ARVN.US)$ I hope everyone bought that sub 14 dip! This thing has been a beast.

Analysts Notebook

Jun 21, 2022 06:06

Columns Top upgrades and downgrades on 6/21: XOM, ADBE, UAA, BEKE and more

Upgrades
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

ARVN Arvinas

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target